2Folkman J.Fundamental concepts of the angiogenic process[J].Curr Mol Med,2003,3(7):643-6:51.
3Folkman J.Antiangiogenesis in cancer therapy endostatin and its mechanisms of actian[J].Exp Cell Res,2006,312(5):594-607.
4Macpherson G R,Ng S S,Forbes S L,et al.Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to tim ing of treatment in a human saphenous vein assay[J].Mol Cancer Ther,2003,2 (9):845-854.
5Folkman J.Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action[J].Exp Cell Res,2006,312 (5):594 -607.
6Jain R K.Normalizing tumor vasculature with anti-angiogenic therapy:a new paradigm for combination therapy[J].Nat Med,2001,7(9):987-989.
7Mancuso M R,Davis R,Norberg S M,et al.Rapid vascular regrowth in tumors after reversal of VEGF inhibition[J].J Clin Invest,2006,116(10):2610-2621.
8Yamaguchi R,Yano H,lemura A,et al.Expression of vascular endothe lial growth factor in human hepatocellular carcinoma[J].Hepatology,1998,28 (1):68-77.
9te Velde E A,Vogten J M,Gebbink M F,et al.Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model[J].Br J Surg,2002,89(10):1302-1309.
